Previous 10 | Next 10 |
ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be partic...
TransMedics to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 PR Newswire ANDOVER, Mass. , Feb. 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming orga...
The shares for Doximity (NYSE: DOCS) , Iqvia Holdings (NYSE: IQV) , and TransMedics Group (NASDAQ: TMDX) are all off to positive starts this year, but what makes them different from other companies is that they are changing healthcare industry standards. Doximity i...
TransMedics Appoints Nick Corcoran as Senior Vice President of Supply Chain and Operations PR Newswire ANDOVER, Mass. , Feb. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming org...
Summary Small caps outperformed the Nasdaq Composite last year as stocks fell due to the Federal Reserve's efforts to control inflation. Market fears are mounting that the economy may slip into a recession, but there are opportunities in small-cap stocks. The potential risk of a lon...
Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...
If you're looking for stocks that can deliver explosive gains, the healthcare sector has you covered, Doximity (NYSE: DOCS) , TransMedics (NASDAQ: TMDX) , and InMode (NASDAQ: INMD) are leading the niche markets where they earn a living, but the stock market doesn't seem to...
Belite Bio (NASDAQ: BLTE) , TransMedics Group (NASDAQ: TMDX) and Rhythm Pharmaceuticals (NASDAQ: RYTM) set themselves apart over the past year with triple-digit share price gains. Each of the healthcare companies is developing something unique, whether it be finding trea...
Very few investors will look back on 2022 fondly, with the S&P 500 average down 19.4% and the Dow Jones Industrial Average down 8.9%. Even healthcare stocks (which generally weather economic downturns well) are down this year, with the Fidelity MSCI Healthcare ETF down roughly 6.8...
This has been an absolutely dismal year for growth stocks. The Vanguard Growth ETF has fallen about 33% over the past 12 months. While times have been tough for most growth stocks, shares of TransMedics Group (NASDAQ: TMDX) have more than tripled in 2022. Investors reacted to expl...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...